Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Lauretta, R., Sansone, M., Sansone, A., Romanelli, F., & Appetecchia, M
Llabani E, Hicklin RW, Lee HY, Motika SE, Crawford LA, Weerapana E, et al
276 Lauffenburgers early modeling revealed how negative feedback quantitatively controls MAPK signal adaptation, and his concept of temporal collateral sensitivity shows that tumor evolution creates transient windows of drug susceptibility, supporting adaptive therapy
Gastroenterology (2017) 153(2):4209
Semin Diagn Pathol 10(1):4775 Becker JC, Zur Hausen A (2014) Cells of origin in skin cancer
A 2006 Phase I trial of CJC-1295 reported no serious adverse events across a small number of subjects, but it was a safety study, not an outcomes trial, and there are no large trials showing it does what enthusiasts hope
US$ 29.01
US$ 23.92
US$ 27.26
US$ 29.37
